Epidemiology and treatment outcome of mucormycosis in Khuzestan, Southwest of Iran

Archives of Clinical Infectious Diseases

Volumn 12, Issue 1, 2017, Pages

  Nashibi, Roohangiz ^a   Afzalzadeh, Sara ^a   Mohammadi, Mohammad Javad ^a,b   Yari, Ahmad Reza ^c   Yousefi, Farid ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ABADAN SCHOOL OF MEDICAL SCIENCES   (Iran)

^c QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Mucormycosis; Outcome

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CLINICAL ARTICLE; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DEBRIDEMENT; DEMOGRAPHY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRAN; LABORATORY TEST; MALE; MUCORMYCOSIS; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; RURAL AREA; TREATMENT RESPONSE; WINTER;

EID: 85011655154     PISSN: 23452641     EISSN: 20081081     Source Type: Journal    
DOI: 10.5812/archcid.37221     Document Type: Article

References (31)

1. Kontoyiannis DP, Lewis RE. In: Agents of mucormycosis and entomophthoramycosis. 7 ed. Mandell GL, Bennett JE, Dolin R, editors. Churchill livingstone; 2010.
2. Chowdhary A, Agarwal K, Meis JF. Filamentous Fungi in Respiratory Infections. What Lies Beyond Aspergillosis and Mucormycosis?. PLoS Pathog. 2016;12(4):1005491. doi: 10.1371/journal.ppat.1005491. [PubMed: 27124489].
3. Sharma D, Dahal K, Pathak B, Dahal U. Case of early-disseminated Rhizopus microsporus var. microsporus mucormycosis in a renal transplant patient. Int Med Case Rep J. 2016;9:139–43. doi: 10.2147/IMCRJ.S100395. [PubMed: 27354831].
4. Vaezi A, Moazeni M, Rahimi M, Hoog S, Badali H. Mucormycosis in Iran: a systematic review. Mycoses. 2016.
5. Chakrabarti A, Singh R. Mucormycosis in India: unique features. Mycoses. 2014;57 Suppl 3:85–90. doi: 10.1111/myc.12243. [PubMed: 25187095].
6. Epstein JB, Kupferman SB, Zabner R, Rejali A, Hopp ML, Lill M, et al. Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review. Supportive Care Cancer. 2016:1–4.
7. Faraji E, Nakhjavani M, Mashrabi O, Maleki S, Maleki R. A brief review of mucormycosis: Report of five cases. BJMMR. 2016;11(9):1–5.
8. Yari AR, Goudarzi G, Geravandi S, Dobaradaran S, Yousefi F, Idani E, et al. Study of ground-level ozone and its health risk assessment in residents in Ahvaz city, Iran during 2013. Toxin Reviews. 2016;35(3-4):201–6.
9. Park JH, Park SH, Kang EG, Kyung G, An HD, An S. Cutaneousmucormycosis in a patient with diabetes mellitus. Ewha Med J. 2016;39(1):10–3.
10. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S23–34. doi: 10.1093/cid/cir866. [PubMed: 22247442].
11. Miceli MH, Kauffman CA. Treatment options for mucormycosis. Cur Treat Options Infect Dis. 2015;7(3):142–54.
12. Mendez HH, Hidalgo A. Endodontic patient with rhinocerebral mucormycosis. Revista Odontologica Mexicana. 2015;19(2):120–5.
13. Lim MY, Alker AP, Califano S, Trembath DG, Alby K, Gilligan PH, et al. Concurrent Disseminated Nocardiosis and GI Mucormycosis in a Stem-Cell Transplantation Recipient. J Clin Oncol. 2016;34(10):84–6. doi: 10.1200/JCO.2013.51.4042. [PubMed: 25071136].
14. Hong HL, Lee YM, Kim T, Lee JY, Chung YS, Kim MN, et al. Risk factors for mortality in patients with invasive mucormycosis. Infect Chemother. 2013;45(3):292–8. doi: 10.3947/ic.2013.45.3.292. [PubMed: 24396630].
15. Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214–25. doi: 10.1056/NEJMoa1204781. [PubMed: 23215557].
16. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53. doi: 10.1086/432579. [PubMed: 16080086].
17. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S16–22. doi: 10.1093/cid/cir865. [PubMed: 22247441].
18. Goudarzi G, Geravandi S, Foruozandeh H, Babaei AA, Alavi N, Niri MV, et al. Cardiovascular and respiratory mortality attributed to groundlevel ozone in Ahvaz, Iran. Environ Monit Assess. 2015;187(8):487. doi: 10.1007/s10661-015-4674-4. [PubMed: 26141926].
19. Salmanzadeh S, Yousefi F, Ahmadi F, Geravandi S, Moien M, Mohammadi M, et al. Evaluation of Nosocomial Infections in a Teaching Hospital. Avicenna J Clin Microbiol Infect. 2015;2(3).
20. Mohinisingh D. Mucormycosis an Emerging Fungal Infection. Indian J app Res. 2015;5(8):661–4.
21. Sachdeva K. Rhino-oculo Cerebral Mucormycosis with Multiple Cranial Nerve Palsy in Diabetic Patient: Review of Six Cases. Indian J Otolaryngol Head Neck Surg. 2013;65(4):375–9. doi: 10.1007/s12070-013-0659-1. [PubMed: 24427603].
22. Saegeman V, Maertens J, Ectors N, Meersseman W, Lagrou K. Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital. Med Mycol. 2010;48(2):245–54. doi: 10.1080/13693780903059477. [PubMed: 19568978].
23. Khor B, Lee M, Leu H, Liu J. Rhinocerebral mucormycosis in Taiwan. J microbiol immunol infect. 2003;36(4):266–9.
24. Barati M, Talebi-Taher M, Nojomi M, Kerami F. Ten-year experience of rhinocerebral zygomycosis in a teaching hospital in Tehran. Arch Clin Infect Dis. 2010;5(3):117–20.
25. Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009;15(9):1395–401. doi: 10.3201/eid1509.090334. [PubMed: 19788806].
26. Sarvestani AS, Pishdad G, Bolandparvaz S. Predisposing factors for mucormycosis in patients with diabetes mellitus; an experience of 21 years in southern iran. Bulletin Emerg Traum. 2013;1(4):164.
27. Komur S, Inal A, Kurtaran B, Ulu A, Uguz A, Aksu H, et al. Mucormycosis: a 10-year experience at a tertiary care center in Turkey. Turkish JMed Sci. 2016;46(1):58–62.
28. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99(2):331–6. [PubMed: 9375750].
29. Bartzokas CA. Relationship between the metereological conditions and the air-borne fungal flora of the Athens metropolitan area. Mycopathologia. 1975;57(1):35–8. [PubMed: 1207718].
30. El-Herte RI, Baban TA, Kanj SS. Mucormycosis: a review on environmental fungal spores and seasonal variation of human disease. Adv Infect Dis. 2012;2(03):76.
31. Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44(4):335–42. doi: 10.1080/13693780500464930. [PubMed: 16772227].